All Stories

  1. CRISPR metabolic screen unveiled KEAP1 as a gene of resistance to ATM inhibitors.

    Article • Proceedings of the National Academy of Sciences, February 2023, Proceedings of the National Academy of Sciences

    Urbain Weyemi